{"id":10104,"date":"2024-09-09T05:15:59","date_gmt":"2024-09-09T05:15:59","guid":{"rendered":"https:\/\/investinnavarra.com\/?p=10104"},"modified":"2024-09-26T08:17:50","modified_gmt":"2024-09-26T08:17:50","slug":"rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project","status":"publish","type":"post","link":"https:\/\/investinnavarra.com\/en\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\/","title":{"rendered":"Rokote Laboratories adds 3PBIOVIAN to its anti-COVID vaccine project"},"content":{"rendered":"<h3>The Finnish multinational will use the active substance and the pharmaceutical product provided by 3PBIOVIAN to develop a mucosal immune response in nasopharyngeal cells. These usually act as the main entry point for the virus. From there, the collaboration between the two companies will allow the former to take the clinical studies of its intranasal vaccine FINCoVac 2.1 to Phase I.<\/h3>\n<p>Rokote Laboratories is one of the world&#8217;s leading specialists in advanced vaccine technologies, with a particular focus on intranasal vaccines that induce mucosal immunity. Using adenoviral vector technologies, it aims to \u2018improve the efficacy and safety of vaccines\u2019. In response to the COVID-19 pandemic, the company developed \u2018a nasal spray vaccine, an easy-to-administer, non-invasive option, complementary to existing vaccines\u2019.<\/p>\n<p>The agreement with 3PBIOVIAN covers the GMP manufacture of the Ad5 vector for Phase I clinical trials, using the company&#8217;s standard process at its facilities in Turku, Finland. In response to Rokote&#8217;s \u2018urgent needs\u2019, the programme moved towards GMP production with \u2018exceptional speed\u2019, thanks to 3PBIOVIAN&#8217;s\u00a0extensive experience in adenovirus-based processes.<\/p>\n<h3>ASSESSMENT OF THE AGREEMENT<\/h3>\n<p>\u2018We are delighted to partner with 3PBIOVIAN for the manufacture of our next-generation intranasal COVID-19 vaccine. Their ability to use standardised processes for rapid GMP batch production, coupled with their vast experience in adenoviruses, makes them an ideal partner. We look forward to moving forward together in the development of Finnish vaccines,\u2019 said Erkko Yl\u00f6sm\u00e4ki, CEO of Rokote Laboratories.<\/p>\n<p>D\u00e1maso Molero, CEO of 3PBIOVIAN, underlined the importance of the collaboration: \u2018It is an honour that Rokote Laboratories has chosen us to manufacture their innovative adenovirus-based candidate. The combination of 3P Biopharmaceuticals and Biovian enables us to offer high-tech therapeutic solutions, as in this case.<\/p>\n<p>Antti Nieminen, deputy CEO of 3PBIOVIAN, added: \u2018With two decades of experience in viral vector process development and adenovirus production under GMP standards, we are proud to be involved in the development of this second-generation coronavirus vaccine, moving it towards clinical trials\u2019.<\/p>\n<p>3PBIOVIAN is one of the main players in Navarra&#8217;s biomedical ecosystem. The industry employs 31,508 people in the region. Most of them work in healthcare services (27,981), although we should also highlight the 2,465 jobs linked to the health industry and the 1,065 researchers. In one of our last reports, we detailed the level of growth and the growing strength that this sector is achieving in its efforts to become a benchmark at European level. This is detailed in <a href=\"https:\/\/investinnavarra.com\/en\/informe\/health-the-fastest-growing-sector-in-navarra-seeks-to-become-a-bio-health-benchmark-in-europe\/\"><strong>this link<\/strong><\/a>.<\/p>\n<p>Fuente:\u00a0<strong><a href=\"https:\/\/navarracapital.es\/la-navarra-3p-biovian-y-la-finlandesa-rokote-laboratories-fabricaran-una-vacuna-contra-el-covid-19\/\">Navarra Capital<\/a><\/strong><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Finnish multinational will use the active substance and the pharmaceutical product provided by 3PBIOVIAN to develop a mucosal immune response in nasopharyngeal cells. These usually act as the main entry point for the virus. From there, the collaboration between the two companies will allow the former to take the clinical studies of its intranasal [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":4978,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36],"tags":[],"class_list":["post-10104","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-en-health"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rokote Laboratories adds 3PBIOVIAN to its anti-COVID vaccine project &#8226; Invest In Navarra<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/investinnavarra.com\/en\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rokote Laboratories adds 3PBIOVIAN to its anti-COVID vaccine project &#8226; Invest In Navarra\" \/>\n<meta property=\"og:description\" content=\"The Finnish multinational will use the active substance and the pharmaceutical product provided by 3PBIOVIAN to develop a mucosal immune response in nasopharyngeal cells. These usually act as the main entry point for the virus. From there, the collaboration between the two companies will allow the former to take the clinical studies of its intranasal [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/investinnavarra.com\/en\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\/\" \/>\n<meta property=\"og:site_name\" content=\"Invest In Navarra\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-09T05:15:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-26T08:17:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/investinnavarra.com\/wp-content\/uploads\/2022\/08\/3P_bio_-Laboratories.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1100\" \/>\n\t<meta property=\"og:image:height\" content=\"733\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"jjimenez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"jjimenez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\\\/\"},\"author\":{\"name\":\"jjimenez\",\"@id\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/#\\\/schema\\\/person\\\/3271fbb2f754855399e4f49e5d8fd2df\"},\"headline\":\"Rokote Laboratories adds 3PBIOVIAN to its anti-COVID vaccine project\",\"datePublished\":\"2024-09-09T05:15:59+00:00\",\"dateModified\":\"2024-09-26T08:17:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\\\/\"},\"wordCount\":413,\"publisher\":{\"@id\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/investinnavarra.com\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/3P_bio_-Laboratories.jpg\",\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\\\/\",\"url\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\\\/\",\"name\":\"Rokote Laboratories adds 3PBIOVIAN to its anti-COVID vaccine project &#8226; Invest In Navarra\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/investinnavarra.com\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/3P_bio_-Laboratories.jpg\",\"datePublished\":\"2024-09-09T05:15:59+00:00\",\"dateModified\":\"2024-09-26T08:17:50+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/investinnavarra.com\\\/en\\\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\\\/#primaryimage\",\"url\":\"https:\\\/\\\/investinnavarra.com\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/3P_bio_-Laboratories.jpg\",\"contentUrl\":\"https:\\\/\\\/investinnavarra.com\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/3P_bio_-Laboratories.jpg\",\"width\":1100,\"height\":733},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/\",\"name\":\"Invest In Navarra\",\"description\":\"Herramienta del Gobierno de Navarra para atraer nuevas inversiones a Navarra\",\"publisher\":{\"@id\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/#organization\",\"name\":\"Invest In Navarra\",\"url\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/investinnavarra.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/logo-invest-v1-b.png\",\"contentUrl\":\"https:\\\/\\\/investinnavarra.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/logo-invest-v1-b.png\",\"width\":768,\"height\":277,\"caption\":\"Invest In Navarra\"},\"image\":{\"@id\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/#\\\/schema\\\/person\\\/3271fbb2f754855399e4f49e5d8fd2df\",\"name\":\"jjimenez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ade3fb65769cac937dd1b8724a80c14840369b3ec9d786f9351b09a53d7d9664?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ade3fb65769cac937dd1b8724a80c14840369b3ec9d786f9351b09a53d7d9664?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ade3fb65769cac937dd1b8724a80c14840369b3ec9d786f9351b09a53d7d9664?s=96&d=mm&r=g\",\"caption\":\"jjimenez\"},\"url\":\"https:\\\/\\\/investinnavarra.com\\\/en\\\/author\\\/jjimenez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rokote Laboratories adds 3PBIOVIAN to its anti-COVID vaccine project &#8226; Invest In Navarra","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/investinnavarra.com\/en\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\/","og_locale":"en_US","og_type":"article","og_title":"Rokote Laboratories adds 3PBIOVIAN to its anti-COVID vaccine project &#8226; Invest In Navarra","og_description":"The Finnish multinational will use the active substance and the pharmaceutical product provided by 3PBIOVIAN to develop a mucosal immune response in nasopharyngeal cells. These usually act as the main entry point for the virus. From there, the collaboration between the two companies will allow the former to take the clinical studies of its intranasal [&hellip;]","og_url":"https:\/\/investinnavarra.com\/en\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\/","og_site_name":"Invest In Navarra","article_published_time":"2024-09-09T05:15:59+00:00","article_modified_time":"2024-09-26T08:17:50+00:00","og_image":[{"width":1100,"height":733,"url":"https:\/\/investinnavarra.com\/wp-content\/uploads\/2022\/08\/3P_bio_-Laboratories.jpg","type":"image\/jpeg"}],"author":"jjimenez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"jjimenez","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/investinnavarra.com\/en\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\/#article","isPartOf":{"@id":"https:\/\/investinnavarra.com\/en\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\/"},"author":{"name":"jjimenez","@id":"https:\/\/investinnavarra.com\/en\/#\/schema\/person\/3271fbb2f754855399e4f49e5d8fd2df"},"headline":"Rokote Laboratories adds 3PBIOVIAN to its anti-COVID vaccine project","datePublished":"2024-09-09T05:15:59+00:00","dateModified":"2024-09-26T08:17:50+00:00","mainEntityOfPage":{"@id":"https:\/\/investinnavarra.com\/en\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\/"},"wordCount":413,"publisher":{"@id":"https:\/\/investinnavarra.com\/en\/#organization"},"image":{"@id":"https:\/\/investinnavarra.com\/en\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\/#primaryimage"},"thumbnailUrl":"https:\/\/investinnavarra.com\/wp-content\/uploads\/2022\/08\/3P_bio_-Laboratories.jpg","articleSection":["Health"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/investinnavarra.com\/en\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\/","url":"https:\/\/investinnavarra.com\/en\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\/","name":"Rokote Laboratories adds 3PBIOVIAN to its anti-COVID vaccine project &#8226; Invest In Navarra","isPartOf":{"@id":"https:\/\/investinnavarra.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/investinnavarra.com\/en\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\/#primaryimage"},"image":{"@id":"https:\/\/investinnavarra.com\/en\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\/#primaryimage"},"thumbnailUrl":"https:\/\/investinnavarra.com\/wp-content\/uploads\/2022\/08\/3P_bio_-Laboratories.jpg","datePublished":"2024-09-09T05:15:59+00:00","dateModified":"2024-09-26T08:17:50+00:00","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/investinnavarra.com\/en\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/investinnavarra.com\/en\/rokote-laboratories-adds-3p-biovian-to-its-anti-covid-vaccine-project\/#primaryimage","url":"https:\/\/investinnavarra.com\/wp-content\/uploads\/2022\/08\/3P_bio_-Laboratories.jpg","contentUrl":"https:\/\/investinnavarra.com\/wp-content\/uploads\/2022\/08\/3P_bio_-Laboratories.jpg","width":1100,"height":733},{"@type":"WebSite","@id":"https:\/\/investinnavarra.com\/en\/#website","url":"https:\/\/investinnavarra.com\/en\/","name":"Invest In Navarra","description":"Herramienta del Gobierno de Navarra para atraer nuevas inversiones a Navarra","publisher":{"@id":"https:\/\/investinnavarra.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/investinnavarra.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/investinnavarra.com\/en\/#organization","name":"Invest In Navarra","url":"https:\/\/investinnavarra.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/investinnavarra.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/investinnavarra.com\/wp-content\/uploads\/2022\/05\/logo-invest-v1-b.png","contentUrl":"https:\/\/investinnavarra.com\/wp-content\/uploads\/2022\/05\/logo-invest-v1-b.png","width":768,"height":277,"caption":"Invest In Navarra"},"image":{"@id":"https:\/\/investinnavarra.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/investinnavarra.com\/en\/#\/schema\/person\/3271fbb2f754855399e4f49e5d8fd2df","name":"jjimenez","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/ade3fb65769cac937dd1b8724a80c14840369b3ec9d786f9351b09a53d7d9664?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ade3fb65769cac937dd1b8724a80c14840369b3ec9d786f9351b09a53d7d9664?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ade3fb65769cac937dd1b8724a80c14840369b3ec9d786f9351b09a53d7d9664?s=96&d=mm&r=g","caption":"jjimenez"},"url":"https:\/\/investinnavarra.com\/en\/author\/jjimenez\/"}]}},"_links":{"self":[{"href":"https:\/\/investinnavarra.com\/en\/wp-json\/wp\/v2\/posts\/10104","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/investinnavarra.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/investinnavarra.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/investinnavarra.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/investinnavarra.com\/en\/wp-json\/wp\/v2\/comments?post=10104"}],"version-history":[{"count":6,"href":"https:\/\/investinnavarra.com\/en\/wp-json\/wp\/v2\/posts\/10104\/revisions"}],"predecessor-version":[{"id":10206,"href":"https:\/\/investinnavarra.com\/en\/wp-json\/wp\/v2\/posts\/10104\/revisions\/10206"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/investinnavarra.com\/en\/wp-json\/wp\/v2\/media\/4978"}],"wp:attachment":[{"href":"https:\/\/investinnavarra.com\/en\/wp-json\/wp\/v2\/media?parent=10104"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/investinnavarra.com\/en\/wp-json\/wp\/v2\/categories?post=10104"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/investinnavarra.com\/en\/wp-json\/wp\/v2\/tags?post=10104"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}